Predictive Oncology Inc (POAI) Company Profile & Statistics

Predictive Oncology Inc
POAI
(Nasdaq - US)
N/A
1.61
-0.15 (-8.52%)
in:usd•As of: May 10, 2024 13:09 UTC -4
Open
1.75
High
1.77
Low
1.61

About Predictive Oncology Inc

CEO

Raymond F. Vennare

Headquarters

91 43rd street,suite 110

pittsburgh, pa 15201, united states

Auditor

Baker Tilly US, LLP

Employees

Share Holders

155

Website

https://predictive oncology.com/

Industry

medical specialties

Sector

health technology

Company Overview

Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.

Predictive Oncology Inc Statistics

Valuation Measures

Market Capitalization ²	6.54M
Enterprise Value	-2.04M
Enterprise Value/EBITDA (ttm)	0.15
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.85
Price to Sales (ttm)	3.97
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	57.09%
Operating Margin (ttm)	-778.32%
Profit Margin (ttm)	-926.65%
Return on Equity (ttm)	-104.21%
Return on Invested Capital (ttm)	-114.29%
Return on Assets (ttm)	-70.49%

Income Statement

Revenue (ttm)	1.78M
Revenue Per Share (ttm)	0.44
Gross Profit (ttm)	1.15M
EBITDA (ttm)³	-13.34M
Net Income Avi to Common (ttm)	-13.98M
Diluted EPS (ttm)	-3.47

Share Statistics

Beta (5Y Monthly)	1.39
52-Week Change	-58.18%
S&P500 52-Week Change	26.07%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	4.06M
Dividend Yield	0.00%
Float ⁴	3.92M
% Held by Insiders	3.44%
% Held by Institutions	9.04%

Balance Sheet

Total Cash (mrq)	8.73M
Total Cash Per Share (mrq)	2.15
Total Debt (mrq)	150.40K
Total Debt/Equity (mrq)	1.82%
Current Ratio (mrq)	2.55%
Quick Ratio (mrq)	2.43%
Book Value Per Share (mrq)	2.04

Cash Flow

Operating Cash Flow Per Share (ytd)	-3.29
Free Cash Flow (ytd)	-13.47M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Predictive Oncology Inc

Trade With A Regulated Broker